A Multicenter, Open Label Phase I/II Study of Carfilzomib, Pomalidomide and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma (MM) Patients

Sara Bringhen, Mario Boccadoro, Alessandra Larocca et al.|Blood|2016

Cited by 7